217 related articles for article (PubMed ID: 32021108)
1. Enhancing Betulinic Acid Dissolution Rate and Improving Antitumor Activity via Nanosuspension Constructed by Anti-Solvent Technique.
Li S; Zhang J; Fang Y; Yi J; Lu Z; Chen Y; Guo B
Drug Des Devel Ther; 2020; 14():243-256. PubMed ID: 32021108
[TBL] [Abstract][Full Text] [Related]
2. [Preparation and characterization of icariin nanosuspension and lyophilized powder].
Hui-Rong XI; Hui-Ping MA; Ke-Ming C; Xiao-Shuan L
Zhongguo Zhong Yao Za Zhi; 2020 Oct; 45(20):4902-4908. PubMed ID: 33350263
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-betulinic acid hybrid nanosuspensions for enhanced anti-breast cancer activity.
Wang R; Yang M; Li G; Wang X; Zhang Z; Qiao H; Chen J; Chen Z; Cui X; Li J
Colloids Surf B Biointerfaces; 2019 Feb; 174():270-279. PubMed ID: 30469048
[TBL] [Abstract][Full Text] [Related]
4. Development and in vitro evaluation of deacety mycoepoxydiene nanosuspension.
Wang Y; Liu Z; Zhang D; Gao X; Zhang X; Duan C; Jia L; Feng F; Huang Y; Shen Y; Zhang Q
Colloids Surf B Biointerfaces; 2011 Apr; 83(2):189-97. PubMed ID: 21176876
[TBL] [Abstract][Full Text] [Related]
5. Development of an amorphous nanosuspension by sonoprecipitation-formulation and process optimization using design of experiment methodology.
Gajera BY; Shah DA; Dave RH
Int J Pharm; 2019 Mar; 559():348-359. PubMed ID: 30721724
[TBL] [Abstract][Full Text] [Related]
6. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy.
Saneja A; Kumar R; Singh A; Dhar Dubey R; Mintoo MJ; Singh G; Mondhe DM; Panda AK; Gupta PN
Int J Pharm; 2017 Oct; 531(1):153-166. PubMed ID: 28823888
[TBL] [Abstract][Full Text] [Related]
7. Study of Formulation and Process Variables for Optimization of Piroxicam Nanosuspension Using 3
Alhamhoom Y; Honmane SM; Hani U; Osmani RAM; Kandasamy G; Vasudevan R; Paramshetti S; R Dudhal R; K Kengar N; Charde MS
Polymers (Basel); 2023 Jan; 15(3):. PubMed ID: 36771784
[TBL] [Abstract][Full Text] [Related]
8. Enhanced Solubility and Dissolution Rate of Lacidipine Nanosuspension: Formulation Via Antisolvent Sonoprecipitation Technique and Optimization Using Box-Behnken Design.
Kassem MAA; ElMeshad AN; Fares AR
AAPS PharmSciTech; 2017 May; 18(4):983-996. PubMed ID: 27506564
[TBL] [Abstract][Full Text] [Related]
9. Development of olmesartan medoxomil optimized nanosuspension using the Box-Behnken design to improve oral bioavailability.
Nagaraj K; Narendar D; Kishan V
Drug Dev Ind Pharm; 2017 Jul; 43(7):1186-1196. PubMed ID: 28271908
[TBL] [Abstract][Full Text] [Related]
10. Characterization and in vitro studies of the anticancer effect of oxidized carbon nanotubes functionalized with betulinic acid.
Tan JM; Karthivashan G; Arulselvan P; Fakurazi S; Hussein MZ
Drug Des Devel Ther; 2014; 8():2333-43. PubMed ID: 25429205
[TBL] [Abstract][Full Text] [Related]
11. Isoliquiritigenin Nanosuspension Enhances Cytostatic Effects in A549 Lung Cancer Cells.
Qiao F; Zhao Y; Mai Y; Guo J; Dong L; Zhang W; Yang J
Planta Med; 2020 May; 86(8):538-547. PubMed ID: 32294789
[TBL] [Abstract][Full Text] [Related]
12. The relevancy of controlled nanocrystallization on rifampicin characteristics and cytotoxicity.
Mohyeldin SM; Mehanna MM; Elgindy NA
Int J Nanomedicine; 2016; 11():2209-22. PubMed ID: 27274244
[TBL] [Abstract][Full Text] [Related]
13. Preparation and in-vitro/in-vivo evaluation of curcumin nanosuspension with solubility enhancement.
Li X; Yuan H; Zhang C; Chen W; Cheng W; Chen X; Ye X
J Pharm Pharmacol; 2016 Aug; 68(8):980-8. PubMed ID: 27283220
[TBL] [Abstract][Full Text] [Related]
14. Preparation, Characterization, and Evaluation of Breviscapine Nanosuspension and Its Freeze-Dried Powder.
Zhang T; Li X; Xu J; Shao J; Ding M; Shi S
Pharmaceutics; 2022 Apr; 14(5):. PubMed ID: 35631508
[TBL] [Abstract][Full Text] [Related]
15. [Preparation of herpetolide A nanosuspension lyophilized powder and evaluation of its anti-hepatitis B virus activity].
Zhong YJ; Liu QC; Zhang T; Liu X; Wang LQ; Yuan HL
Zhongguo Zhong Yao Za Zhi; 2020 Mar; 45(5):1076-1081. PubMed ID: 32237449
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of isradipine nanosuspension by anti-solvent microprecipitation-high-pressure homogenization method for enhancing dissolution rate and oral bioavailability.
Shelar DB; Pawar SK; Vavia PR
Drug Deliv Transl Res; 2013 Oct; 3(5):384-91. PubMed ID: 25788346
[TBL] [Abstract][Full Text] [Related]
17. Herpetetrone nanosuspensions enhance drug solubility and bioavailability to improve anti-hepatic fibrosis effects.
Zhong Y; Hang L; Wang F; Shen B; Shen C; Xue Y; Jia H; Wang L; Yuan H
J Microencapsul; 2023 Dec; 40(8):587-598. PubMed ID: 37733492
[TBL] [Abstract][Full Text] [Related]
18. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.
Freag MS; Elnaggar YS; Abdallah OY
Int J Pharm; 2013 Sep; 454(1):462-71. PubMed ID: 23830765
[TBL] [Abstract][Full Text] [Related]
19. Development of a chemically stable 10-hydroxycamptothecin nanosuspensions.
Pu X; Sun J; Wang Y; Wang Y; Liu X; Zhang P; Tang X; Pan W; Han J; He Z
Int J Pharm; 2009 Sep; 379(1):167-73. PubMed ID: 19505545
[TBL] [Abstract][Full Text] [Related]
20. Betulinic acid self-assembled nanoparticles for effective treatment of glioblastoma.
Li Y; Wang Y; Gao L; Tan Y; Cai J; Ye Z; Chen AT; Xu Y; Zhao L; Tong S; Sun Q; Liu B; Zhang S; Tian D; Deng G; Zhou J; Chen Q
J Nanobiotechnology; 2022 Jan; 20(1):39. PubMed ID: 35062946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]